Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 221

1.

Bilateral hemifacial spasm: a report of five cases and a literature review.

Tan EK, Jankovic J.

Mov Disord. 1999 Mar;14(2):345-9. Review.

PMID:
10091632
2.

[Bilateral hemifacial spasm: case report].

Machado FC, Fregni F, Campos CR, Limongi JC.

Arq Neuropsiquiatr. 2003 Mar;61(1):115-8. Epub 2003 Apr 16. Review. Portuguese.

3.

[Hemifacial spasm].

Krystkowiak P.

Ann Dermatol Venereol. 2009 May;136 Suppl 4:S142-5. doi: 10.1016/S0151-9638(09)74542-9. French.

PMID:
19576481
4.

Hemifacial spasm: clinical findings and treatment.

Wang A, Jankovic J.

Muscle Nerve. 1998 Dec;21(12):1740-7.

PMID:
9843077
5.

[Essential blepharospasm and hemifacial spasm: characteristic of the patient, botulinum toxin A treatment and literature review].

Schellini SA, Matai O, Igami TZ, Padovani CR, Padovani CP.

Arq Bras Oftalmol. 2006 Jan-Feb;69(1):23-6. Epub 2006 Feb 10. Review. Portuguese.

6.

Bilateral hemifacial spasm: a series of 10 patients with literature review.

Felício AC, Godeiro-Junior Cde O, Borges V, Silva SM, Ferraz HB.

Parkinsonism Relat Disord. 2008;14(2):154-6. Epub 2007 Aug 16.

PMID:
17702626
8.

Childhood-onset hemifacial spasm: successful treatment with botulinum toxin.

Singer C, Papapetropoulos S, Farronay O.

Pediatr Neurol. 2005 Sep;33(3):220-2.

PMID:
16139741
9.

Clinico-radiologic correlation in unilateral and bilateral hemifacial spasm.

Tan EK, Chan LL.

J Neurol Sci. 2004 Jul 15;222(1-2):59-64.

PMID:
15240197
10.

Hemifacial spasm: results of treatment with low dose botulinum toxin injection.

Suputtitada A, Phanthumchinda K, Locharernkul C, Suwanwela NC.

J Med Assoc Thai. 2004 Oct;87(10):1205-11.

PMID:
15560699
11.

Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm.

Ababneh OH, Cetinkaya A, Kulwin DR.

Clin Exp Ophthalmol. 2014 Apr;42(3):254-61. doi: 10.1111/ceo.12165. Epub 2013 Aug 4.

PMID:
23844601
12.

[Ocular wavefront aberrations in patients with facial dystonia treated with botulinum toxin].

Yabiku MM, Sartori Jde F, Sarraff EP, Osaki TH, Hossaka SK, Pereira CI, Freitas Wd, Osaki MH, Cariello AJ.

Arq Bras Oftalmol. 2011 Nov-Dec;74(6):414-6. Portuguese.

13.

Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm.

Cakmur R, Ozturk V, Uzunel F, Donmez B, Idiman F.

J Neurol. 2002 Jan;249(1):64-8.

PMID:
11954870
15.

[Clinical symptoms, diagnosis and treatment of focal dystonias].

Klivényi P, Vécsei L.

Orv Hetil. 2001 Oct 21;142(42):2293-7. Hungarian.

PMID:
11760645
16.

Long-term botulinum toxin treatment of benign essential blepharospasm, hemifacial spasm, and Meige syndrome.

Czyz CN, Burns JA, Petrie TP, Watkins JR, Cahill KV, Foster JA.

Am J Ophthalmol. 2013 Jul;156(1):173-177.e2. doi: 10.1016/j.ajo.2013.02.001. Epub 2013 Mar 28.

PMID:
23541393
17.
18.
19.

[Lacrimal film evaluation of patients with facial dystonia during botulinum toxin type A treatment].

Costa PG, Cardoso IP, Saraiva FP, Raiza AC, Tanaka LK, Matayoshi S.

Arq Bras Oftalmol. 2006 May-Jun;69(3):319-22. Portuguese.

20.

Hemifacial spasm caused by vertebral artery dolichoectasia.

Rahman EA, Trobe JD, Gebarski SS.

Am J Ophthalmol. 2002 Jun;133(6):854-6.

PMID:
12036693

Supplemental Content

Support Center